Polypharmacy at the End of Life: Why Are So Many Patients Still Taking Statins and Bisphosphonates?

Evidence-based clinical review Polypharmacy at the End of Life: Why Are So Many Patients Still Taking Statins and Bisphosphonates? A prognosis- and goals-based approach to preventive medications, with important exceptions for recent ASCVD, high fracture risk, and active cancer indications Estimated

Small Fiber Neuropathy: When EMG Is Normal but the Patient Is Not

Evidence-based clinical review Small Fiber Neuropathy: When EMG Is Normal but the Patient Is Not A practical framework for recognizing the phenotype, confirming small-fiber dysfunction, finding treatable causes, and avoiding diagnostic overreach Abstract Background: Small fiber neuropathy

Outpatient Community-Acquired Pneumonia in 2026: Are We Still Treating Too Broadly?

Evidence-based clinical review Outpatient Community-Acquired Pneumonia in 2026: Are We Still Treating Too Broadly? Updated: September 2, 2026 | Estimated reading time: 15 minutes Abstract Background Outpatient community-acquired pneumonia (CAP) is a common setting for

CIDP Overdiagnosis and IVIG Stewardship: Are We Treating the Right Patients for the Right Duration?

CIDP Overdiagnosis and IVIG Stewardship: Are We Treating the Right Patients for the Right Duration? Review Abstract Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a highly treatable immune-mediated neuropathy. However, establishing the diagnosis requires a careful integration of the clinical phenotype, electrodiagnostic findings, appropriate supportive evidence,

Frailty Before the ICU: Using Frailty Scores to Guide Escalation Without Turning Them Into Gatekeepers

Frailty Before the ICU: Using Frailty Scores to Guide Escalation Without Turning Them Into Gatekeepers Review Abstract Purpose: Frailty has emerged as an important predictor of adverse outcomes in hospitalized and critically ill adults, particularly among older patients with multiple chronic conditions. As healthcare systems increasingly care

Resistant Hypertension Gets Personal: Aldosterone, Renin, and the Renewed Secondary Workup

Resistant Hypertension Gets Personal: Aldosterone, Renin, and the Renewed Secondary Workup Review Abstract Purpose: Resistant hypertension remains a significant clinical challenge and is associated with a markedly increased risk of cardiovascular disease, chronic kidney disease progression, stroke, heart failure, and premature mortality. Despite the availability of multiple

Vestibular Migraine in Neurology Clinics: The Great Mimicker Behind Recurrent Vertigo

Vestibular Migraine in Neurology Clinics The Great Mimicker Behind Recurrent Vertigo Review Abstract Purpose: Vestibular migraine is increasingly recognized as one of the most common neurological causes of recurrent episodic vertigo and dizziness, yet it remains substantially underdiagnosed and frequently misclassified in routine clinical practice. Patients

GlobalRPh Vancomycin Dosing and Bayesian AUC Advanced Calculator

Introducing the GlobalRPh Vancomycin Dosing and Bayesian AUC Calculator Advanced (Beta) Five population models, conventional pharmacokinetics, Bayesian forecasting, and clinician-directed AUC dosing in one platform A formal introduction to the Advanced calculator's conventional AUC workflow, Bayesian mathematics, five population-specific models, model-selection safeguards, and clinician-directed

RSV Monoclonal Antibodies: A Paradigm Shift in Infant Protection

RSV Monoclonal Antibodies: A Paradigm Shift in Infant Protection Review Abstract Purpose: This review examines the evolving role of long-acting respiratory syncytial virus monoclonal antibodies in preventing RSV lower respiratory tract disease in infants and selected young children. Methodology: This article reviews current CDC and

Albuminuria as a Vital Sign: Why Urine ACR Is Becoming Central to Kidney-Cardiovascular Risk Assessment

Albuminuria as a Vital Sign: Why Urine ACR Is Becoming Central to Kidney-Cardiovascular Risk Assessment Review Abstract Albuminuria, most commonly assessed using the urine albumin-to-creatinine ratio (ACR), has emerged as one of the most valuable biomarkers in contemporary nephrology and cardiovascular medicine. Despite its proven clinical

Polypharmacy at the End of Life: Why Are So Many Patients Still Taking Statins and Bisphosphonates?